Oligodendrocyte Progenitor Cell Culture From Human Brain

Status Completed

Clinical Trial Summary

Recent developments in the understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or focal transplantation of such cells. Clinical trials of stem- or progenitor cell transplantation in multiple sclerosis are currently premature. The researchers developed a protocol for human oligodendrocyte progenitor cell culture from human brain for the treatment of demyelinating disease.

Clinical Trial Description

Oligodendrocyte progenitor cell line were cultures and will be transplanted into the patient with Multiple sclerosis. ;

Study Design

Related Conditions & MeSH terms

Demyelinating Diseases

Clinical Trial Details

NCT number	NCT00283023
Study type	Interventional
Source	Rajavithi Hospital
Contact
Status	Completed
Phase	Phase 1
Start date	December 2007
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05199363` - Pediatric Patient Experience on a Diagnostic Path	N/A
Terminated	`NCT01963650` - Natural History Study of Children With Metachromatic Leukodystrophy
Recruiting	`NCT05792176` - Ukulele Playing to Improve Cognition in People With Multiple Sclerosis: A Feasibility Study	N/A
Completed	`NCT04837651` - Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
Not yet recruiting	`NCT06065670` - Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy	Phase 1/Phase 2
Active, not recruiting	`NCT03562975` - Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
Completed	`NCT01056471` - Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis	Phase 1/Phase 2
Recruiting	`NCT04762342` - Power Training in Older Multiple Sclerosis Patients	N/A
Completed	`NCT00001287` - Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Phase 2
Completed	`NCT03268239` - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions	N/A
Recruiting	`NCT05605951` - Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve
Recruiting	`NCT04539002` - Aerobic Exercise for Remyelination in Multiple Sclerosis	Phase 1/Phase 2
Recruiting	`NCT05834855` - Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS	Phase 3